Ketamine (Beckley Psytech)

氯胺酮 (Eleusis)

Report date: 2024/02/06 13:05:24

Base Information

Drug NameKetamine (Beckley Psytech)
Drug Alias NameELE-Ket+
ClassificationSmall molecules
Mechanisms of ActionGlutamate [NMDA] receptor antagonistsGlutamate receptor ionotropic AMPA agonists
TargetsGlutamate [NMDA] receptorGlutamate receptor ionotropic AMPA
Therapy Area/IndicationsDepressive Disorder, Major
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaN/A
Originator CompaniesEleusis Holdings Ltd
China Registration ClassN/A

Develop Information

Active CompaniesEleusis Holdings Ltd
Inactive CompaniesN/A
Active IndicationsDepressive Disorder, Major
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A